Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Arcus Biosciences, Inc. (RCUS)

NYSE - NYSE Delayed Price. Currency in USD
35.71+1.25 (+3.63%)
At close: 04:00PM EST
34.80 -0.91 (-2.55%)
After hours: 07:51PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close34.46
Open34.12
Bid31.36 x 800
Ask35.74 x 800
Day's Range33.81 - 36.13
52 Week Range16.74 - 47.00
Volume932,213
Avg. Volume764,793
Market Cap2.586B
Beta (5Y Monthly)0.61
PE Ratio (TTM)27.90
EPS (TTM)1.28
Earnings DateFeb 21, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est45.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-26% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RCUS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Arcus Biosciences, Inc.
    RCUS: Raising target price to $36.00ARCUS BIOSCIENCES INC has an Investment Rating of HOLD; a target price of $36.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
Advertisement
Advertisement